Matsushita, T. Et Al. 2023. Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.. The New England journal of medicine , vol.389, no.9 , 783-794.

Matsushita, T., Shapiro, A., Abraham, A., Angchaisuksiri, P., Castaman, G., Cepo, K., ... d'Oiron, R.(2023). Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.. The New England journal of medicine , vol.389, no.9, 783-794.

Matsushita, Tadashi Et Al. "Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.," The New England journal of medicine , vol.389, no.9, 783-794, 2023

Matsushita, Tadashi Et Al. "Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.." The New England journal of medicine , vol.389, no.9, pp.783-794, 2023

Matsushita, T. Et Al. (2023) . "Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.." The New England journal of medicine , vol.389, no.9, pp.783-794.

@article{article, author={Tadashi Matsushita Et Al. }, title={Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.}, journal={The New England journal of medicine}, year=2023, pages={783-794} }